Mechanisms of SARS-CoV-2 transmission and pathogenesis
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marks
the third highly pathogenic coronavirus to spill over into the human population. SARS-CoV-2 …
the third highly pathogenic coronavirus to spill over into the human population. SARS-CoV-2 …
Immunological considerations for COVID-19 vaccine strategies
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
[PDF][PDF] COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing
Kwok-Yung Yuen Email: kyyuen@ hku. hk Phone number:(852)-22552413 Carol Yu Centre
for Infection, State Key Laboratory of Emerging Infectious Diseases, Department of …
for Infection, State Key Laboratory of Emerging Infectious Diseases, Department of …
[HTML][HTML] Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity
Limited knowledge is available on the relationship between antigen-specific immune
responses and COVID-19 disease severity. We completed a combined examination of all …
responses and COVID-19 disease severity. We completed a combined examination of all …
Suboptimal SARS-CoV-2−specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype
JR Habel, THO Nguyen… - Proceedings of the …, 2020 - National Acad Sciences
An improved understanding of human T cell-mediated immunity in COVID-19 is important for
optimizing therapeutic and vaccine strategies. Experience with influenza shows that …
optimizing therapeutic and vaccine strategies. Experience with influenza shows that …
Disharmonic inflammatory signatures in COVID-19: augmented neutrophils' but impaired monocytes' and dendritic cells' responsiveness
Z Parackova, I Zentsova, M Bloomfield, P Vrabcova… - Cells, 2020 - mdpi.com
COVID-19, caused by SARS-CoV-2 virus, emerged as a pandemic disease posing a severe
threat to global health. To date, sporadic studies have demonstrated that innate immune …
threat to global health. To date, sporadic studies have demonstrated that innate immune …
Covid-19: perspectives on innate immune evasion
The ongoing outbreak of Coronavirus disease 2019 infection achieved pandemic status on
March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide …
March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide …
The immuno-oncological challenge of COVID-19
L Derosa, C Melenotte, F Griscelli, B Gachot… - Nature Cancer, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …
considerable challenges for the management of oncology patients. COVID-19 presents as a …
[HTML][HTML] The immunology of SARS-CoV-2 infections and vaccines
L Grigoryan, B Pulendran - Seminars in immunology, 2020 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19, emerged in late 2019, and was
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
Z Li, S Niu, B Guo, T Gao, L Wang, Y Wang… - Cell …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 …
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 …